WASHINGTON, Aug 24 (Reuters) – Pharmaceutical company Mylan
NV has won a round in its fight with Teva Pharmaceutical
Industries Ltd at the U.S. Patent and Trademark
Office, which said on Wednesday…
The post Mylan wins round in fight with Teva over multiple sclerosis drug appeared first on NASDAQ.